 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Protalix BioTherapeutics Inc. (PLX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2015-10-19 Purchase | 2015-10-20 2:18 pm | Protalix BioTherapeutics Inc. | PLX | Camber Capital Management LLC 10% Owner | 4,000,423 | $1 | $4,000,436 | 13,275,000 (Indirect) | View |
| 2015-12-14 Purchase | 2015-12-15 07:30 am | Protalix BioTherapeutics Inc. | PLX | Maimon Yossi CFO | 10,000 | $0.78 | $7,800 | 10,000 (Indirect Direct) | View |
| 2016-12-02 Sale | 2016-12-06 3:26 pm | Protalix BioTherapeutics Inc. | PLX | Camber Capital Management LLC 10% Owner | 2,500,000 | $0.3168 | $792,000 | 10,775,000 (Indirect) | View |
| 2017-05-16 Purchase | 2017-05-16 09:31 am | Protalix BioTherapeutics Inc. | PLX | Manor Moshe CEO | 50,000 | $0.81 | $40,500 | 50,000 (Direct) | View |
| 2020-04-07 Purchase | 2020-04-13 4:05 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 64,000 | $2.426 | $155,264 | 64,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-09-15 Exercise | 2016-09-16 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Shaaltiel Yoseph VP | 122,162 | $0.001 | 0 (Direct) | View |
| 2016-09-15 Exercise | 2016-09-16 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Shaaltiel Yoseph VP | 122,162 | $0.001 | 0 (Direct) | View |
| 2018-09-13 Option Award | 2018-09-14 4:30 pm | N/A 2028-09-13 | Protalix BioTherapeutics Inc. | PLX | Shaaltiel Yoseph VP | 700,000 | $0.56 | 700,000 (Direct) | View |
| 2018-09-13 Option Award | 2018-09-14 4:30 pm | N/A 2028-09-13 | Protalix BioTherapeutics Inc. | PLX | Manor Moshe CEO | 1,300,000 | $0.56 | 1,300,000 (Direct) | View |
| 2018-09-13 Option Award | 2018-09-14 4:30 pm | N/A 2028-09-13 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron VP | 600,000 | $0.56 | 600,000 (Direct) | View |
| 2018-09-13 Option Award | 2018-09-14 4:31 pm | N/A 2028-09-13 | Protalix BioTherapeutics Inc. | PLX | Almon Einat Brill VP | 700,000 | $0.56 | 700,000 (Direct) | View |
| 2018-09-13 Option Award | 2018-09-14 4:31 pm | N/A 2028-09-13 | Protalix BioTherapeutics Inc. | PLX | Maimon Yossi CFO | 700,000 | $0.56 | 700,000 (Direct) | View |
| 2019-06-30 Option Award | 2019-07-02 5:56 pm | N/A 2029-06-30 | Protalix BioTherapeutics Inc. | PLX | Bashan Dror CEO | 1,600,000 | $0.469 | 1,600,000 (Direct) | View |
| 2019-09-22 Option Award | 2019-09-24 5:01 pm | N/A 2029-09-22 | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal CFO | 800,000 | $0.2 | 800,000 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:01 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director | 40,000 | $3.55 | 40,000 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:02 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 40,000 | $3.55 | 40,000 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:02 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 40,000 | $3.55 | 40,000 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:03 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 40,000 | $3.55 | 40,000 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:03 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Granot David Director | 40,000 | $3.55 | 40,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 5:01 pm | N/A 2030-02-03 | Protalix BioTherapeutics Inc. | PLX | Bronfeld Zeev Director | 240,000 | $3.7 | 240,000 (Direct) | View |
| 2020-06-07 Option Award | 2020-06-08 5:07 pm | N/A 2030-06-07 | Protalix BioTherapeutics Inc. | PLX | Almon Einat Brill SVP Chief Development Officer | 196,995 | $3.59 | 196,995 (Direct) | View |
| 2020-07-05 Option Award | 2020-07-08 5:01 pm | N/A 2030-07-05 | Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP | 129,771 | $3.73 | 129,771 (Direct) | View |
| 2020-08-11 Option Award | 2020-08-13 5:01 pm | N/A 2030-08-11 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron VP | 122,656 | $3.59 | 122,656 (Direct) | View |
| 2020-08-11 Option Award | 2020-08-13 5:02 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror CEO | 447,927 | $0 | 447,927 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-13 5:03 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal CFO | 246,146 | $0 | 246,146 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-14 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror CEO | 447,927 | $0 | 447,927 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-14 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal CFO | 246,146 | $0 | 246,146 (Indirect) | View |